Activity of cefditoren against β-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis

Diagnostic Microbiology and Infectious Disease

Volumn 42, Issue 1, 2002, Pages 53-58

  Karlowsky, James A ^a   Critchley, Ian A ^a   Draghi, Deborah C ^a   Jones, Mark E ^b   Thornsberry, Clyde ^a   Sahm, Daniel F ^a  

^a Focus Technologies Incorporated   (United States)

^b Focus Technologies   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFDITOREN; CEFTRIAXONE; COTRIMOXAZOLE; LEVOFLOXACIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; DRUG ACTIVITY; DRUG POTENCY; ENZYME SYNTHESIS; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL;

BETA-LACTAMASES; CEPHALOSPORINS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; PROSPECTIVE STUDIES;

EID: 0036159388     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00331-5     Document Type: Article

References (22)

1. Haemophilus
2. Efficacy of cefditoren pivoxil versus amoxicillin/clavulanate in acute maxillary sinusitis
3. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study
4. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study
5. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program
6. Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: Results of a 1992-1993 Western Europe and USA collaborative surveillance study
7. An in vitro characterization of cefditoren, a new oral cephalosporin
8. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens: Findings of the Alexander Project 1992-1996
9. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria
10. Cefditoren is safe and effective treatment for streptococcal pharyngitis
11. Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid
12. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species
13. A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents
14. Isolation of an ampicillin-resistant, non-β-lactamase-producing strain of Haemophilus influenzae
15. Cefditoren is safe and effective treatment for uncomplicated skin and skin structure infections
16. Acinetobacter, Achromobacter, Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative gram-negative rods
17. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998
18. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective U.S. study
19. Ampicillin-resistant Haemophilus influenzae type b infection
20. Safety and efficacy of cefditoren in acute exacerbation of chronic bronchitis